Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
05/26 Anacor received rival bid before Pfizer deal - filing
05/22 TEVA CFO : We'll close Allergan deal next month
05/22 ALLERGAN : Launches 'IBS-D on Tract,' New Online Resource to Support..
 SummaryQuotesNewsCalendarCompanyFinancials 
Company
Allergan, Inc. operates as a global healthcare company.It engages in the developing and commercializing innovative specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity... 
Sector
Pharmaceuticals
Calendar
07/27Earnings Release
More about the company
Latest news on ALLERGAN, INC.
05/26 Anacor received rival bid before Pfizer deal - filing
05/22 TEVA CFO : We'll close Allergan deal next month
05/22 ALLERGAN : Launches 'IBS-D on Tract,' New Online Resource to Support Patients wi..
05/18 ALLERGAN : expansion approved for $13 million city tax deal, awaits $4 million c..
05/17 PFIZER : moves on from Allergan deal collapse with new $5.2bn takeover
05/16 Pfizer buying skin drug maker Anacor for $5.2 billion
05/16 Pfizer to buy eczema drugmaker Anacor for $5.2B
05/16 ALLERGAN : Reinforces Commitment to Hypertension Management with Four Poster Pre..
05/14 TEVA PHARMACEUTICAL : Can Teva Pharmaceutical Industries Ltd (ADR) Survive Gener..
05/14 Baupost took $461 million Allergan stake before Pfizer deal collapsed
More news
Sector news : Pharmaceuticals - NEC
05/28 SUN PHARMACEUTICAL : Pharma Q4 profit seen up 113%, Gleevec may drive US sales
05/28 TAKEDA PHARMACEUTICAL : Receives Positive CHMP Opinion for ADCETRIS (brentuximab..
05/28DJSUBSCRIBERS : Covestro News Reported in April
05/28DJCovestro Eyes Acquisitions, Says Finance Chief - Report
05/28 ASTRAZENECA : S faslodex met primary endpoint in first-line treatment of advance..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Technical analysis trends ALLERGAN, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials